In the epilepsy foci study of human specimens, our data indicates a similar trend, although the number of samples was limited, i.e., the ARHGDIA expression levels in the ACTH treatment group (P1, P2) were higher than those in the non-treatment group (P3 to P5). The gene discussed is POMC; the disease is epilepsy.